GEL SWEEPER FOR RESIDUAL STONE FRAGMENT REMOVAL
Systems and methods for performing medical procedures in body lumens are described. Embodiments of the methods include forming a plug to partially or fully occlude the lumen and moving the plug through a surgical field. Embodiments of the systems include an elongate body graspable by a surgical instrument or by a surgeon that are adapted to anchor to the plug.
Latest Boston Scientific Scimed, Inc. Patents:
This application claims priority to 61/788,413 filed Mar. 15, 2013. This application is related to U.S. Pat. No. 7,963,944 issued Jun. 21, 2001, by Sahatjian et al. entitled “Immobilizing Objects in the Body,” the entire disclosure of which is hereby incorporated by reference for all purposes.TECHNICAL FIELD
The invention relates to medical systems and methods for retrieving material from within a body and, more particularly, to methods and systems for removing calculi or concretions such as kidney stones and gallstones from a body lumen of a patient.BACKGROUND
It is often medically necessary or advisable to remove hard matter, such as kidney stones, gallstones, or foreign bodies from the body of a patient to avoid adverse effects including pain, infection and blockage of body lumens. Removal of hard matter can be done by open surgery, but it is preferable to remove hard matter by minimally-invasive means when possible. Non-invasive removal of hard matter generally involves advancing a specialized device such as a ureteroscope, endoscope, or laparoscope (any or all of which are referred to generally as a “scope”) to the location of the hard matter and either retrieving it using a retrieval device such as a stone retrieval basket or pulverizing it by applying energy to the hard matter with, for example, a laser (termed “lithotripsy”).
When hard matter is pulverized within a body lumen of a patient, however, the fragments of the hard matter may migrate away from the energy source (termed “retropulsion”). Stone fragments that migrate away from sites of lithotripsy can act as nuclei for the formation of new calculi or concretions and can cause other complications. To minimize the risk of fragment migration, it has become common in lithotripsy procedures to deploy an antiretropulsion device such as the BackStop® polymer system commercialized by Pluromed, Inc. (Woburn, Mass.) and sold by Boston Scientific Corporation (Natick, Mass.). However, the use of antiretropulsion devices inevitably adds time and complexity to lithotripsy procedures. As the average cost of operating room time in the US is $15-$25 per minute, there is an ongoing need to minimize the complexity and time required to deploy and retrieve antiretropulsion devices. (Stahl, J et al., Reorganizing patient care and workflow in the operating room: a cost-effectiveness study, Surgery, 139:717-728, 2006.)SUMMARY OF THE INVENTION
Embodiments of the current invention reduce the time required for lithotripsy by providing a streamlined mechanism for simultaneously removing polymeric antiretropulsion devices and stone fragments generated during a lithotripsy procedure.
In one aspect, embodiments of the invention provide a sweeper gel system for collecting calculi and preventing retropulsion during a lithotripsy procedure. The system includes, generally, a flowable polymer formulation that is able to form a plug when it is introduced into a body lumen, and an elongated body that has a first end graspable by a medical instrument and a second end adapted to secure the elongated body within the plug. In various embodiments, the plug is tacky, the first end of the elongated body includes a loop or a hook, and the second end can include a plurality of flanges or flukes to secure the elongated body to the plug.
In another aspect, embodiments of the invention provide a method of treating a patient that includes forming a polymer plug in a body lumen of the patient and moving the polymer plug through the body lumen. The method optionally includes contacting the plug with a calculus or concretion within the body lumen. Other embodiments of the invention provide a method of treating a patient that includes flowing a polymer formulation into a body lumen of a patient and forming a tacky plug occluding the lumen, performing a medical procedure in a field next to the plug, and moving the plug through the field to clear debris in the field. In some embodiments, the method may include positioning a resilient elongate body in the path of the flowing polymer formulation so that the elongate body protrudes from the plug, and moving the plug by grasping the elongate body with a medical instrument. The elongate body optionally includes a shank with first and second ends, in which the first end has a ring or enlargement that can be grasped by a medical instrument and the second end includes flanges or flukes that secure the shank to the plug. In various embodiments, the polymer formulation includes a polymer that forms a solid or a highly viscous liquid within the body, which polymer is optionally a poloxamer, alginate, polyethylene glycol, polyvinyl alcohol, or hyaluronic acid.
In yet another aspect, embodiments of the invention provide a kit for performing a medical procedure in a body lumen that includes an elongate body and a polymer formulation capable of forming a plug when flowed into a body lumen.
In the drawings, like reference characters refer to like features through the different views. The drawings are not necessarily to scale, with emphasis being placed on illustration of the principles of the invention.
Various exemplary sweeper gel systems 100 for collecting fragmented calculi generated during a medical procedure such as lithotripsy are shown in
At the second end 150, the elongate body 120 includes means for securing the elongate body 120 to the polymer plug 110. In the exemplary embodiment of
The elongate body 120 is, in preferred embodiments, formed from a compliant material selected to minimize the potential for damage body tissues should the elongate body 120 become dislodged from the plug 110 or otherwise impinge upon or impact a body tissue. Suitable materials include, without limitation, silicone, polycaprolactone, polylactic acid, poly(lactic-co-glycolic acid), polyethylene oxide, polypropylene, and other materials known to those of skill in the medical arts. The polymer is preferably biocornpatible and optionally bioresorbable. The polymer is optionally, but not necessarily, an elastomer. Additionally, the elongate body 120 can, in some instances, be made of multiple materials, for example having a loop 141 at its first end 140 comprising a loop of suture material and comprising a silicone shank 130 and second end 150. In addition, the elongate body 120 is preferably sufficiently elastic to allow the second end to expand from a relatively compressed, small diameter to a relatively large diameter.
The elongate body 120 preferably has a relatively simple shape, such as those shown in
The plug 110 is formed by flowing a polymer formulation into a body lumen. As used herein, the term “flowing” refers to the introduction of a fluid—a liquid or a gel—through a catheter, while the term “flowable” refers to a fluid or a gel that can be introduced into a body lumen by flowing. Polymer formulations suitable for use in the invention optionally undergo a phase transition during or soon after their introduction into the body: in a first phase, the polymer formulation is characterized by a relatively low viscosity to facilitate flowing the polymer formulation into a body lumen. Once the polymer formulation has entered the body, it preferably transitions into a second phase characterized by a higher viscosity and greater adhesion, which promote the formation of a plug 110 that occludes the lumen and is characterized by a sufficiently high shear modulus or otherwise has sufficient mechanical integrity to remain intact when acted upon by forces applied via the elongate body 120.
Polymer formulations that are configured to undergo a phase transition can comprise one or more low critical solution temperature (LCST) materials, as described in Sahatjian et al. The critical solution temperature—the temperature at which a given material transitions from liquid to gel form—of such LCST materials is advantageously between room temperature (at which LCST materials are liquid) and body temperature (at which LCST materials are gel). Suitable LCST materials include polyoxyethylene-polyoxypropylene (PEO-PPO) block copolymers. Exemplary copolymers of this type include Pluronic acid 1127 and F108, which are PEO-PPO block copolymers with molecular weights of 12,600 and 14,600, respectively (BASF, Mount Olive, N.J.). Other suitable LCST materials include Pluronic acid HOS at concentrations of 20-28% (wt/wt) in phosphate buffered saline (PBS); 22.5% Pluronic acid F108 in PBS; 22% Pluronic acid 1108 in PBS; Pluronic acid F127 at 20-35% PBS; 20% Pluronic acid F127 in PBS. More generally, PEO-PPO block copolymers that are LCST materials and that are biocompatible, biodegradable, and exist as a gel at body temperature and a liquid at below body temperature can also be used to form the plug 110. The molecular weight of a suitable material (such as a block copolymer) can be, for example, between 5,000 and 25,000, and more particularly between 7,000 and 15,000, and, for the two specific compounds identified above, 12,600 or 14,600.
Alternatively, or additionally, the phase-transitioning polymer formulations can include one or more cross-linkable polymers, which can be provided in liquid form and which form gels having a suitably high stress modulus when contacted with cross-linking agents. Suitable cross-linkable polymers include, without limitation, polyacrylic acids, polymethacrylic acid, alginic acid, pectinic acids, sodium alginate, potassium alginate, carboxy methyl cellulose, hyaluronic acid, heparin, carboxymethyl starch, carboxymethyl dextran, heparin sulfate, chondroitin sulfate, polyethylene amine, polysaccharides, chitosan, carboxymethyl chitosan, cationic starch or salts thereof. Suitable cross-linking agents include, without limitation, calcium, magnesium, barium, strontium, boron, beryllium, aluminum, iron, copper, cobalt, lead, silver ions, phosphate, citrate, borate, succinate, maleate, adipate and oxalate ions, and, more broadly, anions or cations derived from polybasic organic or inorganic acids.
The polymer formulations, and the plugs 110 formed therefrom, are preferably water soluble or biodegradable so that any occlusions formed using polymer formulations or plugs 110 according to the invention are temporary rather than permanent. For example, a water soluble plug 110 formed within a ureter can advantageously be removed naturally by the urine. In addition, the polymer formulations balance adhesion and cohesion in a manner that permits a plug 110 of the invention to remain intact when dragged through a body lumen (as described in greater detail below) while passing smoothly and without trauma along the walls of the lumen. The plug 110 formed from the polymer formulation is preferably tacky, so that debris contacting the plug 110 adheres to the plug. Physical characteristics such as tackiness and mechanical strength are affected by the contents of the plug, and may be determined or optimized by changing the plug contents. In particular, the choice of polymer, its molecular weight, and the degree of cross-linking all affect the mechanical properties of the plug, and can all be varied so that the plug can be optimized for a particular application.
In a medical procedure according to an embodiment of the invention, the tip of a scope is inserted into a body lumen of a patient so that the tip is proximate to a site at which a surgical procedure will be performed. A polymer formulation of the invention is then flowed from the tip into the body lumen to form a plug 110 that partially or, more preferably, fully occludes the body lumen, thereby preventing the migration of material through the lumen across the plug. In preferred embodiments, the polymer formulation is flowed around an elongate body 120 so that, when the formulation hardens into a plug 110, the second end 140 of the elongate body 120 protrudes from the plug 110. In other embodiments, however, no elongate body is used.
After the plug is formed, the tip of the catheter or scope is optionally withdrawn and a surgical procedure is performed in a field adjacent to the plug 110. During or after the surgical procedure, a suitable instrument—which may be delivered to the field via the catheter or scope—is used to grasp the plug 110. The grasping can be done directly—i.e. such that the instrument contacts the plug directly or indirectly such that the instrument contacts an elongate member 120 embedded in the plug 110. Once the plug 110 has been grasped, the instrument is used to pull the plug through the lumen toward the catheter or scope. Pulling the plug 110 in this manner results in the plug traveling at least partially through the field, and to the extent that any debris from the surgical procedure (such as fragments of a pulverized hard body, blood clots or dislodged tissue) remains within or near the field, it is preferably swept toward the catheter or scope by the motion of the plug 110. Alternatively or additionally, the scope can be moved toward the plug. In preferred embodiments, the elongate body is deployed, the polymer solution is flowed into the body lumen, and the entire system is retrieved using a single instrument, such as a cystoscope. To facilitate the performance of the different steps, the instrument used in the procedure can include multiple lumens, for example a first lumen dedicated to flowing the polymer formulation and a second lumen that contains a grasping instrument for deploying and/or retrieving the elongate body.
in some embodiments, as discussed above, the plug 110 is tacky, such that as the plug 110 is pulled through the field, debris adheres to the plug 110, thereby minimizing the risk that such debris will migrate away from the field and cause complications. The risk of damage to the walls of the body lumen caused by pulling the plug 110 through the field can be reduced by applying an agent to the plug to reduce friction between the plug 110 and the walls of the body lumen. For instance, a user may flow water over the plug to promote dissolution of the plug and/or its return to the liquid phase. Alternatively, the user may apply a lubricating agent to the plug to form a low friction layer between the plug and a wall of the body lumen.
In an alternate embodiment, shown in
The receptacle 160 can have a closed form (e.g. sponges, bags, balloons) or an open form such that it only partially encloses a gel plug (e.g. umbrella or cup shaped). A suitable open structure preferably covers, encloses or contacts a portion of a solidified gel plug that is sufficient to promote the formation of a relatively compact plug that efficiently occludes a body lumen.
The receptacle 160 may be empty, partially filled, or completely filled with the polymer formulation 110 when it is deployed into the body lumen, and a quantity of polymer formulation 110 is preferably added to the receptacle after the receptacle 160 has been positioned in the body lumen. The receptacle optionally has a lubricious outer surface to permit it to be moved within the body lumen after deployment without risking damage to the walls of the lumen. Additionally, the outer surface of the receptacle can be non-porous and non-permeable to the polymer formulation (e.g. a balloon), or it can be perforated to permit the polymer formulation 110 to flow out of the receptacle and, optionally, directly contact the wall of the body lumen.
The receptacle 160 is graspable by a surgical instrument, and optionally includes protrusions, handles, hooks, baskets, or other features to simplify grasping the receptacle. Systems utilizing receptacles can be used in the same settings, and for the same indications, as systems utilizing elongated members. In fact, in some embodiments, the system includes both a receptacle 160 and an elongated member 120.
While the exemplary methods above focus on the use of a plug 110 and/or an elongate member 120 or a receptacle 160 in conjunction with a (presumably separate) surgical procedure, it should be understood that it is not necessary for a separate surgical procedure be performed, and those of skill in the art will appreciate that a system 100 according to an embodiment of the invention can be used on its own to clear debris or matter, hard or soft, solid or liquid, from any body lumen for any reason. Exemplary applications for the systems and methods of the invention include, without limitation: prevention of retropulsion and gathering of fragmented calculi generated from lithotripsy procedures; removal of concretions or calculi generally; kidney stone removal; gallstone removal; removal of arterial plaques; clearing of the bile ducts; clearance of the pancreatic ducts, removal of foreign matter; and hemostasis. Other applications will occur to those of skill in the art.
The phrase “and/or,” as used herein should be understood to mean “either or both” of the elements so conjoined, i.e., elements that are conjunctively present in some cases and disjunctively present in other cases. Other elements may optionally be present other than the elements specifically identified by the “and/or” clause, whether related or unrelated to those elements specifically identified unless clearly indicated to the contrary. Thus, as a non-limiting example, a reference to “A and/or B,” when used in conjunction with open-ended language such as “comprising” can refer, in one embodiment, to A without B (optionally including elements other than B); in another embodiment, to B without A (optionally including elements other than A); in yet another embodiment, to both A and B (optionally including other elements); etc.
The term “consists essentially of” means excluding other materials that contribute to function, unless otherwise defined herein. Nonetheless, such other materials may be present, collectively or individually, in trace amounts.
As used in this specification, the term “substantially” or “approximately” means plus or minus 10% (e.g., by weight or by volume), and in some embodiments, plus or minus 5%. Reference throughout this specification to “one example,” “an example,” “one embodiment,” or “an embodiment” means that a particular feature, structure, or characteristic described in connection with the example is included in at least one example of the present technology. Thus, the occurrences of the phrases “in one example,” “in an example,” “one embodiment,” or “an embodiment” in various places throughout this specification are not necessarily all referring to the same example. Furthermore, the particular features, structures, routines, steps, or characteristics may be combined in any suitable manner in one or more examples of the technology. The headings provided herein are for convenience only and are not intended to limit or interpret the scope or meaning of the claimed technology.
Certain embodiments of the present invention have described above. It is, however, expressly noted that the present invention is not limited to those embodiments, but rather the intention is that additions and modifications to what was expressly described herein are also included within the scope of the invention, Moreover, it is to be understood that the features of the various embodiments described herein were not mutually exclusive and can exist in various combinations and permutations, even if such combinations or permutations were not made express herein, without departing from the spirit and scope of the invention. In fact, variations, modifications, and other implementations of what was described herein will occur to those of ordinary skill in the art without departing from the spirit and the scope of the invention. As such, the invention is not to be defined only by the preceding illustrative description.
1. A method of treating a patient comprising the steps of:
- flowing a polymer formulation into a body lumen of a patient and thereby forming a plug occluding the lumen;
- performing a medical procedure in a field adjacent to the tacky plug; and
- moving the plug through the field, thereby clearing any debris left in the field.
2. The method of claim 1, wherein the plug is tacky.
3. The method of claim 1, wherein (a) the step of flowing a polymer formulation includes positioning a resilient elongate body in the path of the polymer formulation so that the resilient elongate body partially protrudes from the plug, and (b) the step of moving the tacky plug through the field includes grasping the resilient elongated body with a medical instrument.
4. The method of claim 3, wherein the elongate body comprises a shank having first and second ends, the first end comprising a ring or enlargement graspable by a medical instrument, the second end comprising a plurality of flanges or flukes configured to secure the shank to the plug.
5. The method of claim 1, wherein the polymer formulation comprises a polymer that forms a solid or a highly viscous liquid within the body.
6. The method of claim 5, wherein the polymer is selected from the group consisting of a poloxamer, alginate, polyethylene glycol, polyvinyl alcohol, and hyaluronic acid.
7. A system for performing a lithotripsy procedure, the system comprising:
- a flowable polymer formulation capable of forming a tacky plug when flowed into a body lumen; and
- an elongated body having a first end graspable by a medical instrument and a second end adapted to secure the elongated body within the tacky plug.
8. The system of claim 7, wherein the first end of the elongated body includes a loop.
9. The system of claim 7, wherein the first end of the loop includes a bulbous portion.
10. The system of claim 7, wherein the first end of the loop includes a hook.
11. The system of claim 7, wherein the second end includes a plurality of flanges or flukes configured to secure the elongated body to the plug.
12. The system of claim 7, further comprising a receptacle configured to contain at least a portion of the tacky plug.
13. A method of treating a patient comprising the steps of:
- forming a polymer plug within a body lumen of the patient; and
- moving the polymer plug through the body lumen.
14. The method of claim 13, wherein the lumen includes a calculus or concretion, and the step of moving the polymer plug through the body lumen includes contacting the calculus or concretion with the plug.
15. The method of claim 14, wherein the method further includes a step of breaking the calculus or concretion prior to the step of moving the polymer plug through the body lumen.
16. The method of claim 13, further comprising a step of providing an elongated body having a first end graspable by a medical instrument and a second end adapted to secure the elongated body within the polymer plug, wherein the step of forming the polymer plug includes flowing a polymer into the body lumen so as to envelop the second end of the elongated body.
17. The method of claim 13, wherein each of the steps of forming a polymer plug and moving the polymer plug are performed using a cystoscope or an endoscope.
Filed: Mar 13, 2014
Publication Date: Sep 18, 2014
Patent Grant number: 9775631
Applicant: Boston Scientific Scimed, Inc. (Maple Grove, MN)
Inventors: Jamie Li (Lexington, MA), Timothy P. Harrah (Cambridge, MA), William J. Shaw (Cambridge, MA)
Application Number: 14/208,831